Metabolomic analysis sheds light on gut microbes’ role in cardiovascular disease risk Post author: Post published:May 14, 2024 Post category:uncategorized The effect of gut bacteria on non-high-density lipoprotein cholesterol (non-HDL-c) variations. You Might Also Like FDA accepted PD-L1 inhibitor durvalumab for the treatment of endometrial cancer August 5, 2024 AI assistance in radiology shows mixed results for performance March 19, 2024 HKUST researchers unveil eco-friendly disinfectant alternative to chloroxylenol September 6, 2024